Anti-Human CD109 Aptamer(Cat#: CTMM-0124-LH10)
This product is an aptamer which binds to Human CD109 domain with an affinity of 1-50 nM.
Specific Inquiry 
Summary
Specifications
| Target Category |
Protein |
| Target |
CD109 |
| Alternative Names |
CD109 Molecule; CPAMD7; C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 7; 150 KDa TGF-Beta-1-Binding Protein; Platelet-Specific Gov Antigen; DKFZp762L1111; CD109 Antigen; FLJ38569; P180; R150; CD109 Antigen (Gov Platelet Alloantigens); Activated T-Cell Marker CD109; Gov Platelet Alloantigens |
| Gene ID |
135228 |
| UniProt ID |
Q6YHK3 |
| Target Overview |
This gene encodes a glycosyl phosphatidylinositol (GPI)-linked glycoprotein that localizes to the surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signalling by transforming growth factor beta (TGF-beta). Multiple transcript variants encoding different isoforms have been found for this gene. |
| Type |
DNA |
| Species Reactivity |
Human |
| Length |
50-100 nt |
| Affinity (Kd) |
1-50 nM |
| Binding Conditions/Buffer |
Dulbecco's phosphate buffered saline (D-PBS, Ca2+/Mg2+-free) with 4.5 g/L of glucose and 5 mM of MgCl2 added with 0.1 mg/mL of yeast tRNA, and 1 mg/mL of BSA |
| GC Content |
51.22% |
| Molecular Weight |
25406.3 g/mole |
| nmoles/OD260 |
1.122 |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
